Butler John P.

CIK 00015914674 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001591467

Recent Transactions

50 trades

Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2026-02-02$1.39/sh−96,065→ 3,321,124 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2026-02-02$1.41/sh+175,250→ 3,381,483 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2026-02-02$1.39/sh−114,891→ 3,206,233 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2026-02-02$1.39/sh−83,689→ 3,297,794 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2026-02-02$1.39/sh−46,660→ 3,417,189 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2026-01-30+743,000→ 3,463,849 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2026-01-30+1,115,000→ 1,115,000 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2025-03-03$1.83/sh−46,409→ 2,557,921 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2025-02-03$2.10/sh−46,268→ 2,702,312 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2025-02-03$2.10/sh−97,982→ 2,604,330 total
Award
Akebia Therapeutics, Inc.$AKBA
Performance Stock Units
2025-01-31+350,500→ 350,500 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2025-01-31+701,000→ 2,748,580 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2025-01-31+1,051,400→ 1,051,400 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2024-02-29$1.58/sh−46,570→ 2,044,580 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2024-02-27$1.52/sh−37,733→ 2,091,150 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2024-02-01$1.68/sh−46,489→ 2,128,883 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2024-01-31+603,500→ 2,175,372 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2024-01-31+905,200→ 905,200 total
Disposition from Tender
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-10-10−47,824→ 0 total
Disposition to Issuer
Zynerba Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2023-10-10−34,663→ 0 total
Disposition from Tender
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-10-10−32,941→ 47,824 total
Disposition to Issuer
Zynerba Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2023-10-10−71,736→ 0 total
Sale
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-06-14$0.35/sh−115→ 80,765 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-13+71,736→ 71,736 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2023-06-13+47,824→ 80,880 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-03-01$0.88/sh−47,239→ 1,575,242 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-03-01$0.88/sh−38,259→ 1,622,481 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-03-01$0.88/sh−6,370→ 1,568,872 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-02-27$0.81/sh−38,632→ 1,660,740 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2023-01-31+875,000→ 875,000 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Appreciation Right
2023-01-31+635,313→ 635,313 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2023-01-31+293,125→ 1,699,372 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-06-14+34,663→ 34,663 total
Sale
Zynerba Pharmaceuticals, Inc.
Common Stock
2022-06-14$1.01/sh−53→ 33,056 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2022-06-14+23,109→ 33,109 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-03-01$2.17/sh−4,131→ 1,403,247 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-03-01$2.17/sh−24,811→ 1,432,409 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-03-01$2.17/sh−25,031→ 1,407,378 total
Award
Akebia Therapeutics, Inc.$AKBA
Employee Stock Option (Right to buy)
2022-02-28+739,700→ 739,700 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-02-28+293,125→ 1,457,220 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2022-02-28$2.15/sh−25,053→ 1,164,095 total
Award
Zynerba Pharmaceuticals, Inc.
Common Stock
2021-08-03+5,000→ 10,000 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2021-08-03+7,500→ 7,500 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-04-01$3.40/sh−4,109→ 1,152,153 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-03-16+39,520→ 1,156,262 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-03-01$3.40/sh−24,674→ 1,116,742 total
Sale
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-03-01$3.40/sh−25,316→ 1,141,416 total
Award
Akebia Therapeutics, Inc.$AKBA
Employee Stock Option (Right to buy)
2021-02-26+403,600→ 403,600 total
Award
Akebia Therapeutics, Inc.$AKBA
Common Stock
2021-02-26+237,400→ 1,166,732 total
Award
Zynerba Pharmaceuticals, Inc.
Stock Option (right to buy)
2020-06-10+15,000→ 15,000 total

Companies

Recent Filings

Address

C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET

CAMBRIDGE, MA, 02142

View on SEC.gov